Literature DB >> 11423926

Hypophosphataemia in the metabolic syndrome. Gender differences in body weight and blood glucose.

L Håglin1, A Lindblad , L O Bygren.   

Abstract

OBJECTIVE: We examined gender differences in the clustering of risk factors, especially regarding the possible role of serum phosphate (S-P) in obese patients who participated in a 4 week education programme to reduce their excess risk of cardiovascular disease (CVD).
RESULTS: Significantly higher body mass index (BMI) and concentrations of S-P and high density lipids (S-HDL) in serum were found in women (n=1272) than in men (n=993). In women, BMI was inversely correlated with S-P at the time of admission. Also in women (but not in men), changes in BMI and S-P over 1 or 1-1/2 y were inversely correlated. In men (but not in women), S-P level was inversely correlated with age, systolic blood pressure (SBP), diastolic blood pressure (DBP) and blood glucose at the time of admission. In women, S-P increased and DBP decreased, in addition to weight decrease over both 6 months and 1(1/2) y or 1 y. In women (but not in men), significantly higher age, S-P, S-chol, S-TG, S-urate, SBP and DBP values were found with the highest vs the lowest decile of S-Ca.
CONCLUSION: We conclude that higher S-P and S-Ca levels may contribute to the difference in metabolic disturbances occurring in obesity, seen in women vs men.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11423926     DOI: 10.1038/sj.ejcn.1601209

Source DB:  PubMed          Journal:  Eur J Clin Nutr        ISSN: 0954-3007            Impact factor:   4.016


  16 in total

1.  European Obesity Summit (EOS) - Joint Congress of EASOand IFSO-EC, Gothenburg, Sweden, June 1 - 4, 2016: Abstracts.

Authors: 
Journal:  Obes Facts       Date:  2016-05-25       Impact factor: 3.942

2.  Serum Phosphate Is Associated With Fracture Risk: The Rotterdam Study and MrOS.

Authors:  Natalia Campos-Obando; W Nadia H Koek; Elizabeth R Hooker; Bram Cj van der Eerden; Huibert A Pols; Albert Hofman; Johannes Ptm van Leeuwen; Andre G Uitterlinden; Carrie M Nielson; M Carola Zillikens
Journal:  J Bone Miner Res       Date:  2017-03-27       Impact factor: 6.741

3.  Are the effects of nicotinic acid on insulin resistance precipitated by abnormal phosphorous metabolism?

Authors:  Moutasim H Al-Shaer; Hatem S AbuSabha
Journal:  Lipids Health Dis       Date:  2004-10-28       Impact factor: 3.876

4.  Lifestyle diseases and cardiovascular risk factors are interrelated to deficiencies of major substrates in ATP synthesis.

Authors:  Jørn Ditzel; Hans-Henrik Lervang
Journal:  Vasc Health Risk Manag       Date:  2010-10-05

5.  Disturbance of inorganic phosphate metabolism in diabetes mellitus: temporary therapeutic intervention trials.

Authors:  Jørn Ditzel; Hans Henrik Lervang
Journal:  Diabetes Metab Syndr Obes       Date:  2009-10-08       Impact factor: 3.168

6.  High serum phosphate and triglyceride levels in smoking women and men with CVD risk and type 2 diabetes.

Authors:  Lena M Håglin; Birgitta Törnkvist; Lennart O Bäckman
Journal:  Diabetol Metab Syndr       Date:  2014-03-17       Impact factor: 3.320

7.  Serum phosphate, blood pressure, and the metabolic syndrome--20-year follow-up of middle-aged men.

Authors:  Helga Gudmundsdottir; Arne H Strand; Sverre E Kjeldsen; Aud Høieggen; Ingrid Os
Journal:  J Clin Hypertens (Greenwich)       Date:  2008-11       Impact factor: 3.738

8.  Hyperphosphatemia is associated with anemia in adults without chronic kidney disease: results from the National Health and Nutrition Examination Survey (NHANES): 2005-2010.

Authors:  Janet M Wojcicki
Journal:  BMC Nephrol       Date:  2013-08-21       Impact factor: 2.388

9.  Refeeding and metabolic syndromes: two sides of the same coin.

Authors:  O A Obeid; D H Hachem; J J Ayoub
Journal:  Nutr Diabetes       Date:  2014-06-30       Impact factor: 5.097

10.  Phosphorus Supplementation Recovers the Blunted Diet-Induced Thermogenesis of Overweight and Obese Adults: A Pilot Study.

Authors:  Maya S Bassil; Omar A Obeid
Journal:  Nutrients       Date:  2016-12-09       Impact factor: 5.717

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.